How Life Insurance Underwriters View Crohn's Disease and IBD
Life insurance companies do not treat Crohn's disease or ulcerative colitis as an automatic decline. Most modern insurers classify inflammatory bowel disease (IBD) as a chronic but manageable condition, and underwriting focuses on how severe and well-controlled your disease is rather than the diagnosis alone.
Underwriters place applicants into one of three broad severity buckets: mild, moderate, or severe. Where you land depends on flare frequency, hospitalizations, surgeries, medications, and complications. Two people with the same diagnosis can receive very different offers depending on their medical file and the carrier they apply to.
Key underwriting concerns
When reviewing an IBD application, underwriters focus on:
- Disease activity: Are you in remission, or having active flares?
- Treatment intensity: Are you on mild oral 5-ASAs, immunomodulators, or biologics like Humira, Remicade, or Stelara?
- Steroid use: Chronic or high-dose prednisone signals unstable disease.
- Surgical history: Bowel resections, ostomies, fistula repairs, or stricturoplasty add loading.
- Complications: Fistulas, abscesses, strictures, anemia, weight loss, or liver involvement raise risk.
- Time since diagnosis: Applications within 6 months of diagnosis or a severe episode are often postponed.
Typical Rate Classes for Crohn's and Ulcerative Colitis
Life insurance rate classes for IBD range from Preferred (rare) through Standard and into Table ratings (Table 1-8+), with each table adding roughly 25% to base premiums. Here is how disease severity typically maps to rate class and pricing in 2026 for a healthy 35-year-old buying a $500,000 20-year term policy.
| Disease Profile | Likely Rate Class | Approx. Monthly Premium | vs. Standard |
|---|---|---|---|
| No Crohn's/IBD | Preferred/Standard | $24-32 | Baseline |
| Mild, oral meds only, in remission | Standard | $28-38 | +0-25% |
| Moderate, on biologics, controlled | Standard to Table 2 | $35-50 | +25-60% |
| Moderate-severe, recent flare | Table 3-5 | $48-68 | +50-110% |
| Severe, history of surgery | Table 5-7 | $60-85 | +100-165% |
| Very active or diagnosed <6 months ago | Postpone or decline | N/A | N/A |
Mild, well-controlled IBD
If you have been in remission for several years, take only oral maintenance meds, have not been hospitalized recently, and have no significant complications, you can often qualify for Standard rates. Some applicants with excellent overall health and long remission may even see near-Preferred pricing at select carriers.
Moderate IBD
Periodic flares, biologic therapy, or a history of one bowel resection typically puts applicants into a Standard to Table 2 range. Recent diagnosis (within 6 months) or a recent severe episode can push you to Table 2-4.
Severe or complicated IBD
Frequent flares, multiple surgeries, fistulas, strictures, an ostomy, or ongoing high-dose immunosuppression often results in Table 4-8 ratings. Very severe or treatment-refractory cases may be declined by fully underwritten carriers.
Do Biologics Like Humira, Remicade, and Stelara Raise Rates?
This is one of the most common questions from IBD patients, and the answer is nuanced. Biologics themselves are not an automatic penalty. Insurers now view drugs like adalimumab (Humira), infliximab (Remicade), and ustekinumab (Stelara) as mainstream treatment for moderate-to-severe Crohn's and colitis.
However, needing a biologic signals moderate-to-severe disease, and that severity is what drives higher premiums. The good news: if a biologic is clearly working (fewer flares, no hospitalizations, stable labs), underwriters often view your case more favorably than someone with persistent symptoms on weaker medications.
If you are stable on Humira, Remicade, or Stelara for 12+ months with documented remission, emphasize that stability in your application. Bring recent gastroenterologist notes, colonoscopy findings, and labs showing normal CRP and hemoglobin.
Best Life Insurance Companies for IBD Patients
Because insurers weigh IBD very differently, choosing the right carrier can be the difference between Standard rates and a Table 4 rating on the same medical file. These companies are repeatedly identified by specialist brokers as the most Crohn's- and colitis-friendly in 2026.
| Carrier | Best For | IBD Underwriting Reputation |
|---|---|---|
| Prudential | Mild to moderate Crohn's & UC | Most flexible, often the first choice for brokers |
| Corebridge Financial (AIG) | Ulcerative colitis, stable IBD | Can offer up to Standard rates for controlled UC |
| Banner Life / Legal & General America | Well-controlled IBD | Favorable rates, competitive term pricing |
| Lincoln Financial | Applicants on biologics | Handles stable biologic therapy well |
| Transamerica | Case-by-case Crohn's cases | Generally fair underwriting for digestive diseases |
| Principal | Stable IBD | Willing to consider moderate cases |
| Mutual of Omaha | Applicants with complications | Supportive of pre-existing conditions |
| John Hancock | Ulcerative colitis | Solid option through high-risk brokers |
If you have other pre-existing health issues alongside IBD, our guide to life insurance with pre-existing conditions walks through how carriers stack multiple risk factors and which underwriters are most lenient across the board.
How to shop across carriers
Do not apply directly with one company. A declined application stays on the MIB (Medical Information Bureau) record and can hurt future applications. Instead:
- Work with an independent broker who specializes in impaired-risk cases.
- Have the broker informally shop your medical file with 3-5 IBD-friendly carriers.
- Formally apply only with the carrier most likely to issue at your target rate class.
What Underwriters Ask About and What Records They Need
When you apply, expect a detailed set of health questions specific to your IBD. Life insurers typically also order an Attending Physician Statement (APS) from your gastroenterologist and primary care doctor to verify your history.
Common IBD underwriting questions
- What is your exact diagnosis (Crohn's, UC, pancolitis, proctitis)?
- When were you diagnosed, and where in the digestive tract is the disease?
- How often do flares occur, and when was your last one?
- What medications are you on, at what dose, and for how long?
- Have you needed long-term or frequent steroid courses?
- Any ER visits, hospitalizations, or surgeries related to IBD?
- When was your last colonoscopy and what did it show?
- Any complications like fistulas, strictures, or extra-intestinal manifestations?
- Do you have significant weight loss or anemia?
Medical records typically requested
- APS from your gastroenterologist and PCP with clinic notes and treatment plan
- Recent colonoscopy and pathology reports (usually within the past 2 years)
- Hospital discharge summaries for any IBD-related admissions
- Operative notes for any bowel surgery
- Medication history and pharmacy records
- Recent labs: CRP, ESR, hemoglobin, albumin
Strategies to Improve Your Approval Odds and Get Better Rates
The steps you take before applying can dramatically improve your rate class. Underwriters reward evidence of stability and proactive health management.
Before you apply
- Wait for stability. If you were recently diagnosed or had a flare, waiting 6-12 months of documented remission can move you from a postponement to Standard rates.
- Get an updated GI evaluation. A recent clinic note stating "disease in remission" carries real weight.
- Get a current colonoscopy. A recent scope showing mucosal healing is one of the strongest positive signals.
- Document medication stability. Show that you have been on the same effective regimen (biologic or otherwise) for at least a year.
- Optimize modifiable risks. Quit smoking, maintain a healthy BMI, and control blood pressure and cholesterol. Non-IBD factors matter too, similar to how term life insurance rates shift with overall health.
During the application
- Provide a personal cover letter summarizing your disease course, remission status, and specialist follow-up.
- Include your gastroenterologist's contact information and offer to sign the release quickly.
- Choose a term length that matches your need (10, 20, or 30 years) without over-buying.
If your IBD comes with other chronic conditions, cross-reference our guides on life insurance with lupus and life insurance for diabetics for how carriers handle overlapping autoimmune and metabolic conditions.
If You've Been Declined: Guaranteed Issue and Simplified Issue Options
A traditional decline is not the end of the road. Two no-medical alternatives can still put coverage in place, and being previously declined does not disqualify you from either.
Guaranteed issue life insurance
Guaranteed issue policies accept anyone within the age band (typically 45-85), with no health questions or exam. They are ideal if you have severe IBD, an ostomy, active complications, or multiple prior declines.
The tradeoffs: face amounts are capped at roughly $5,000-$25,000 (up to $50,000 at some carriers), premiums are higher per dollar of coverage, and all guaranteed issue policies include a 2-3 year graded benefit period. If you die from natural causes during that waiting period, the insurer typically refunds premiums plus interest rather than paying the full death benefit.
Simplified issue life insurance
Simplified issue is a middle ground. You skip the medical exam but answer a short health questionnaire, and coverage limits are much higher, often $50,000-$750,000 or more. Applicants with moderate but controlled Crohn's or UC (no recent hospitalizations, no pending surgery) can often qualify.
Simplified issue works well if you were declined by a traditional underwriter but your disease is now stable. Pricing is between traditional and guaranteed issue policies.
For more on choosing between underwriting paths, see our overview of pre-existing conditions and life insurance, which compares traditional, simplified, and guaranteed issue options side by side.
Frequently Asked Questions
Can you get life insurance with Crohn's disease?
Yes. Most people with Crohn's disease can qualify for life insurance in 2026, though rates depend heavily on severity and control. Mild, well-controlled Crohn's often earns Standard rates, while moderate-to-severe disease typically results in a table rating (Table 1-6). Only very active or recently diagnosed cases are usually postponed, and even then, guaranteed issue coverage remains available.
Does taking Humira, Remicade, or Stelara automatically raise my premiums?
Biologics do not automatically raise your premiums. Insurers view Humira, Remicade, and Stelara as standard treatment for moderate-to-severe IBD, and being stable on one of these medications can actually help your application. Premiums rise mainly because biologic use signals moderate-severe disease, not because of the drug itself.
How long does Crohn's or UC need to be in remission for the best rates?
Most carriers want to see at least 12 months of documented remission with no flares, hospitalizations, or steroid courses to consider you for Standard rates. Two or more years of stability with a recent normal colonoscopy is even better. If you were recently diagnosed or had a severe flare, waiting 6-12 months before applying can shift your file from postponed to approved.
Can I get no-exam life insurance with Crohn's disease?
Yes. Simplified issue policies require no medical exam and can offer $50,000 to $750,000 or more in coverage if your IBD is well-controlled. If you cannot pass the health questions, guaranteed issue policies accept everyone in the age band with no questions asked, though face amounts are capped around $25,000 and include a 2-3 year graded benefit period.
What should I do if my life insurance application was denied because of Crohn's?
First, ask why. Common denial reasons include a recent diagnosis, active flare, recent surgery, or high-dose steroid use. Work with an impaired-risk broker to informally shop your case with more IBD-friendly carriers like Prudential, Corebridge, or Banner Life. If traditional coverage is still off the table, apply for simplified or guaranteed issue policies, which remain available even after a prior decline.